Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 3
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances.
Cucarull B, Tutusaus A, Rider P, Hernáez-Alsina T, Cuño C, García de Frutos P, Colell A, Marí M, Morales A. Cucarull B, et al. Cancers (Basel). 2022 Jan 26;14(3):621. doi: 10.3390/cancers14030621. Cancers (Basel). 2022. PMID: 35158892 Free PMC article. Review.
Mitochondrial Glutathione: Recent Insights and Role in Disease.
Marí M, de Gregorio E, de Dios C, Roca-Agujetas V, Cucarull B, Tutusaus A, Morales A, Colell A. Marí M, et al. Among authors: cucarull b. Antioxidants (Basel). 2020 Sep 24;9(10):909. doi: 10.3390/antiox9100909. Antioxidants (Basel). 2020. PMID: 32987701 Free PMC article. Review.
A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A, de Gregorio E, Cucarull B, Cristóbal H, Aresté C, Graupera I, Coll M, Colell A, Gausdal G, Lorens JB, García de Frutos P, Morales A, Marí M. Tutusaus A, et al. Among authors: cucarull b. Cell Mol Gastroenterol Hepatol. 2020;9(3):349-368. doi: 10.1016/j.jcmgh.2019.10.010. Epub 2019 Nov 2. Cell Mol Gastroenterol Hepatol. 2020. PMID: 31689560 Free PMC article.
Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.
Tutusaus A, Stefanovic M, Boix L, Cucarull B, Zamora A, Blasco L, de Frutos PG, Reig M, Fernandez-Checa JC, Marí M, Colell A, Bruix J, Morales A. Tutusaus A, et al. Among authors: cucarull b. Oncotarget. 2018 Mar 30;9(24):16701-16717. doi: 10.18632/oncotarget.24673. eCollection 2018 Mar 30. Oncotarget. 2018. PMID: 29682179 Free PMC article.